NXGL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NXGL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. NexGel's Revenue for the three months ended in Sep. 2024 was $2.94 Mil. NexGel's average Accounts Receivable for the three months ended in Sep. 2024 was $0.75 Mil. Hence, NexGel's Receivables Turnover for the three months ended in Sep. 2024 was 3.92.
The historical data trend for NexGel's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NexGel Annual Data | |||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Receivables Turnover | Get a 7-Day Free Trial | 10.54 | 7.70 | 11.00 | 9.50 | 9.56 |
NexGel Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Receivables Turnover | Get a 7-Day Free Trial | 1.16 | 1.21 | 1.85 | 2.14 | 3.92 |
For the Medical Instruments & Supplies subindustry, NexGel's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, NexGel's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where NexGel's Receivables Turnover falls into.
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
NexGel's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as
Receivables Turnover (A: Dec. 2023 ) | |||||||
= | Revenue | / | Average Total Inventories | ||||
= | Revenue (A: Dec. 2023 ) | / ( | (Accounts Receivable (A: Dec. 2022 ) | + | Accounts Receivable (A: Dec. 2023 )) | / | count ) |
= | 4.089 | / ( | (0.222 | + | 0.633) | / | 2 ) |
= | 4.089 | / | 0.4275 | ||||
= | 9.56 |
NexGel's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as
Receivables Turnover (Q: Sep. 2024 ) | |||||||
= | Revenue | / | Average Total Inventories | ||||
= | Revenue (Q: Sep. 2024 ) | / ( | (Accounts Receivable (Q: Jun. 2024 ) | + | Accounts Receivable (Q: Sep. 2024 )) | / | count ) |
= | 2.94 | / ( | (0.605 | + | 0.894) | / | 2 ) |
= | 2.94 | / | 0.7495 | ||||
= | 3.92 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NexGel (NAS:NXGL) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Thank you for viewing the detailed overview of NexGel's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Jerome B Zeldis | director | 8767 E. VIA DE VENTURA, SUITE 190, SCOTTSDALE AZ 85258 |
Drapczuk Adam E Iii | officer: Chief Financial Officer | 6 OAKMONT TERRACE, EAST WINDSOR NJ 08520 |
Steven Mark Glassman | director | 99 LEWIS POINT ROAD, FAIR HAVEN NJ 07704 |
Nachum Stein | director | QUADRAX CORP, 618 MAIN ST PO BOX 1001, WEST WARWICK RI 02893 |
Adam R. Levy | officer: CEO and President | 2 AVENUE OF TWO RIVER SOUTH, RUMSON NJ 07760 |
Scott Robert Henry | director | 34A ATLANTIC AVE., COHASSET MA 02025 |
David Stefansky | director | 850 THIRD AVENUE, SUITE 1801, NEW YORK NY 10022 |
Yaakov Spinrad | director | 3450 OAKTON ST, SKOKIE IL 60076 |
Miranda Jayne Toledano | director | C/O COMPASS THERAPEUTICS, INC., 80 GUEST STREET, SUITE 601, BOSTON MA 02135 |
Bezalel Partners Llc | 10 percent owner | C/O KRIEGER & PRAGER LLP, 39 BROADWAY, STE 920, NEW YORK NY 10006 |
David Ian Johnson | director, officer: Chief Executive Officer | C/O ALLIQUA, INC., 850 3RD AVENUE, 18TH FLOOR, NEW YORK NY 10022 |
Adynxx, Inc. | 10 percent owner | 100 PINE ST., STE. 500, SAN FRANCISCO CA 94111 |
From GuruFocus
By Marketwired • 11-13-2024
By Marketwired • 06-27-2024
By GuruFocus News • 11-23-2024
By Marketwired • 04-18-2024
By Marketwired • 08-14-2023
By Marketwired • 11-11-2024
By Marketwired • 06-11-2024
By sperokesalga sperokesalga • 06-15-2023
By GuruFocus Research • 09-15-2023
By Marketwired • 08-14-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.